Accueil › Cancer du poumon › Virginie › Arlington
Essais cliniques pour Cancer du poumon à Arlington, VA
41 études pour Cancer du poumon recherchent des participants dans et autour de Arlington (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Recrutement en coursPhase 3
- Kaiser Permanente Tysons Corner Medical Center, McLean · à 5 mi
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Recrutement en coursPhase 1/2
- Virginia Cancer Specialists, Fairfax · à 11 mi
Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)
Recrutement en coursPhase 2
- Virginia Cancer Specialists (VCS) ( Site 0408), Fairfax · à 11 mi
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Recrutement en coursPhase 3
- Virginia Cancer Specialists, Fairfax · à 11 mi
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Recrutement en coursPhase 3
- Virginia Cancer Specialists, Fairfax · à 11 mi
A Study of PHN-012 in Patients With Advanced Solid Tumors
Recrutement en coursPhase 1
- PHN-012-001 Site, Fairfax · à 11 mi
Phase 1 Study of PF-08046033 in Advanced Solid Tumors
Recrutement en coursPhase 1
- Inova Schar Cancer Infusion Pharmacy, Fairfax · à 11 mi
- Inova Schar Cancer, Fairfax · à 11 mi
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
Recrutement en coursPhase 2
- Research Site, Fairfax · à 11 mi
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Recrutement en coursPhase 2/3
- Virginia Cancer Specialists - Arlington, Arlington
- Virginia Cancer Specialists, Fairfax · à 11 mi
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Recrutement en coursPhase 1/2
- NEXT Oncology Virginia, Fairfax · à 11 mi
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
Recrutement en coursPhase 1/2
- Next Oncology Virginia Cancer Specialist, Fairfax · à 11 mi
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
Recrutement en coursPhase 1
- NEXT - Virginia, Fairfax · à 11 mi
BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)
Recrutement en coursPhase 3
- Virginia Cancer Specialists, Fairfax · à 11 mi
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Recrutement en coursPhase 1/2
- NEXT Virginia, Fairfax · à 11 mi
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Recrutement en coursPhase 1
- Virginia Cancer Specialists, Fairfax · à 11 mi
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Recrutement en coursPhase 3
- USO - Virginia Cancer Specialists, Fairfax · à 11 mi
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
Recrutement en coursPhase 1
- USO-Virginia Cancer Specialists, PC, Fairfax · à 11 mi
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Recrutement en coursPhase 1/2
- Avenzo Therapeutics Recruiting Site, Fairfax · à 11 mi
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
Recrutement en coursPhase 1
- NEXT Oncology, Fairfax · à 11 mi
The Vanguard Study: Testing a New Way to Screen for Cancer
Recrutement en coursVolontaires sains bienvenus
- Inova Schar Cancer Institute, Fairfax · à 11 mi
- Inova Fair Oaks Hospital, Fairfax · à 11 mi
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
Recrutement en coursPhase 3
- Virginia Cancer Specialists, Fairfax · à 11 mi
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
Recrutement en coursPhase 3
- Virginia Cancer Specialists, Fairfax · à 11 mi
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Recrutement en coursPhase 3
- Inova Schar Cancer Institute, Fairfax · à 11 mi
- Inova Fair Oaks Hospital, Fairfax · à 11 mi
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
Recrutement en coursPhase 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · à 11 mi
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
Recrutement en coursPhase 1/2
- NEXT Virginia, Fairfax · à 11 mi
Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer
Recrutement en coursPhase 1
- NEXT Virginia, Fairfax · à 11 mi
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Recrutement en coursPhase 1/2
- NEXT Oncology Virginia, Fairfax · à 11 mi
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Recrutement en coursPhase 1
- NEXT Virginia, Fairfax · à 11 mi
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Recrutement en coursPhase 1
- Research Site, Fairfax · à 11 mi
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Recrutement en coursPhase 2
- Kaiser Permanente Tysons Corner Medical Center, McLean · à 5 mi
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Recrutement en coursPhase 1
- NEXT Oncology Virginia, Fairfax · à 11 mi
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
Recrutement en coursPhase 1/2
- NEXT Virginia, Fairfax · à 11 mi
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Recrutement en coursPhase 1/2
- Next Oncology Virginia, Fairfax · à 11 mi
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
Recrutement en coursPhase 1/2
- NEXT Oncology, Fairfax · à 11 mi
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Recrutement en coursPhase 2
- Kaiser Permanente Tysons Corner Medical Center, McLean · à 5 mi
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Recrutement en coursPhase 2/3
- Kaiser Permanente Tysons Corner Medical Center, McLean · à 5 mi
A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma
Recrutement en coursPhase 2
- Inova Fairfax Hospital, Fairfax · à 11 mi
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Recrutement en coursPhase 1/2
- Virginia Cancer Specialists, Fairfax · à 11 mi
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Recrutement en coursPhase 1/2
- NEXT Virginia, Fairfax · à 11 mi
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
Recrutement en coursPhase 1
- NEXT Virginia, Fairfax · à 11 mi
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
Recrutement en coursPhase 1/2
- Virginia Cancer Specialists, Fairfax · à 11 mi
Essais pour Cancer du poumon dans d'autres villes
- Houston, TX78 études
- Boston, MA62 études
- New York City, NY60 études
- Los Angeles, CA45 études
- Washington, DC41 études
- Chicago, IL41 études
- Nashville, TN40 études
- Baltimore, MD40 études
- St. Louis, MO39 études
- Columbus, OH37 études
- Philadelphia, PA36 études
- Seattle, WA33 études
Autres études à Arlington
- Cancer du poumon non à petites cellules104 études
- Cancer métastatique53 études
- Cancer colorectal52 études
- Cancer (tous types)48 études
- Cancer du sein46 études
- Cancer de l'ovaire46 études
- Cancer de l'endomètre39 études
- Cancer du pancréas33 études
- Carcinome épidermoïde de la tête et du cou26 études
- Cancer bronchique à petites cellules23 études
- Cancer du sein triple négatif20 études
- Cancer de l'estomac20 études
Source : ClinicalTrials.gov, données récupérées le 5 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.